keyboard_arrow_up

Global H1N1 Vaccines market to grow at a CAGR of 5.40 percent by 2018

Global H1N1 Vaccines Market 2014-2018 is a new market research publication announced by Reportstack. H1N1 influenza (zoonotic) is an infectious disease in humans caused by a variant of the swine H1N1 virus, known as H1N1v virus. The H1N1v virus is a contagious virus which infects nose, throat, and lungs. H1N1 virus is an RNA virus belonging to the Orthomyxoviridae family. Influenza A viruses infect different animal species such as humans, swine, birds, seals, and horses. Influenza A viruses can be subdivided on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutinin. Hemagglutinin component is used by the virus to bind to host cell receptors. This facilitates viral entry into the host cell. Neuraminidase protein enzymatically cleaves terminal sialic acid residues from mucins, thereby allowing the virus to reach underlying cells in the respiratory tract. Elderly people, young children, and people with medical conditions including liver disorders, blood disorders, kidney disorders, chronic lung disease, asthma, and neurodevelopmental and neurological conditions are at a higher risk of getting infected. Influenza vaccines are administered for active immunization against influenza virus. This, in turn, confers protection against influenza disease. Vaccination of high-risk groups prevents unnecessary hospitalizations and premature deaths resulting due to influenza.

The analysts forecast that the Global H1N1 Vaccines market to grow at a CAGR of 5.40 percent over the period 2013-2018. This report covers the present scenario and the growth prospects of the Global H1N1 Vaccines market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of various vaccines administered to prevent human infection caused by H1N1 virus.

The report Global H1N1 Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global H1N1 Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas

• APAC

• EMEA

Key Vendors

• AstraZeneca

• GlaxoSmithKline

• Novartis

• Sanofi Pasteur

Other Prominent Vendors

• Baxter International

• bioCSL

• Mitsubishi Tanabe Pharma

• Protein Sciences Corporation

• Serum Institute of India

• Sinovac Biotech

• Zydus Cadila

Market Driver

• Increased Awareness on H1N1 Influenza

• For a full, detailed list, view our report

Market Challenge

• Antigenic Drift of H1N1v Virus

• For a full, detailed list, view our report

Market Trend

• Emergence of Quadrivalent Vaccines

• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

Complete report available @ Global H1N1 Vaccines Market 2014-2018.